Literature DB >> 2104958

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis.

K E Anderson1, D E Goeger, R W Carson, S M Lee, R B Stead.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104958     DOI: 10.1056/NEJM199002013220507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  66-year-old woman with painless vesicular lesions.

Authors:  Aditya Bardia; Elizabeth A Swanson; Kris G Thomas
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 3.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

4.  The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.

Authors:  S Túri; I Németh; I Varga; T Bodrogi; B Matkovics
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 5.  Controversies in selection of epoetin dosages. Issues and answers.

Authors:  P Zachée
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

Review 6.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01

7.  Porphyria and kidney diseases.

Authors:  Nicolas Pallet; Alexandre Karras; Eric Thervet; Laurent Gouya; Zoubida Karim; Hervé Puy
Journal:  Clin Kidney J       Date:  2018-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.